predict dose for head and neck proton and photon therapy for Oropharyngeal tumors using machine learning. Materials/Methods: 35 patients with head and neck cancer who received postoperative proton radiation therapy were retrospectively identified. Each patient also had an available, corresponding photon-based intensitymodulated (IMRT) plan. DICOM-RT datasets for both proton and photon plans were processed to extract a comprehensive feature-set, including relationships between the PTVs and Organs at Risk (OARs), parameters characterizing the radiation modality, and clinical parameters. Prediction models were developed using patient-matching software to estimate the dose utilizing cross-validation techniques on the feature-set. Specifically, models were created for the PTVs (primary and nodal) and OARs designated to be of high significance in planning (Spinal Cord, Brainstem, Mandible, Oral Cavity, Parotid and Submandibular glands, Larynx). Root mean square out-of-sample error was calculated for these structures for proton and photon plans. Results: We were able to effectively predict dose distributions within the OARs and PTVs for both photon and proton treatments prior to plan development. For photon plans, root mean squared error between predicted and planned dose was within 1.5Gy for all structures. For proton plans, the error between predicted and planned dose to critical structures was within 2.3 Gy.
Purpose/Objective(s): We retrospectively investigated the accuracy, quality and efficiency of using VMAT for the treatment planning of WBRT with hippocampal sparing following RTOG 0933 compliance criteria. Materials/Methods: Ten patients previously treated with non-conformal opposed laterals (NC-WBRT) were retrospectively re-planned for hippocampal sparing using VMAT planning. The hippocampus was volumetrically contoured on fused T1-weighted MRI with planning CT images and hippocampus avoidance zone (HAZ) was generated using a 5 mm uniform margin around the hippocampus. Whole brain tissue minus HAZ was defined as the whole brain planning target volume (WB-PTV). Highly conformal VMAT plans were generated for a prescription dose of 30 Gy in 10 fractions per RTOG 0933 criteria. Two full coplanar arcs with eyes avoidance sectors were used. In addition, doses to other organs at risk (OARs) such as parotid glands, ear canals, scalp etc. were also evaluated. Subsequently, dose delivery efficiency and accuracy of each VMAT plan was assessed by delivering quality assurance (QA) plans with a Map-CHECK device, recording beam on time and measuring plan vs. measured dose agreement using a gamma index. Results: The maximum dose to WB-PTV, mean WB-PTV D2%, and mean WB-PTV D98% were 34.9 AE 0.3 Gy, 33.2 AE 0.4 Gy, and 26.0 AE 0.4 Gy respectively. WB-PTV received the prescription dose of 30 Gy and mean V30 was 90.5 AE 0.5%. The D100%, mean and maximum doses to hippocampus were 8.4 AE 0.3 Gy, 11.2 AE 0.3 Gy and 15.6 AE 0.3 Gy, on average, respectively. Mean values of homogeneity index (HI) and conformity index (CI) were 0.23 AE 0.02 and 0.96 AE0.02, respectively. The maximum point dose to WB-PTV was 35.3 Gy, well below the optic pathway tolerance of 37.5Gy. Compared to NC-WBRT, dose reduction of mean and max of parotid glands from VMAT were 65% and 50%, respectively. Ear canals mean and max doses were reduced by 26% and 12%, and mean and maximal scalp doses were reduced by 9 Gy (32%) and 2 Gy (6%), on average, respectively. The mean values of the total number of monitor units (MUs) and actual beam on time were (719 AE 44) and (2.3 AE 0.1) min, respectively. The accuracy of RA QA plan delivery was 98.1 AE 0.8%, on average, with a 3%/3 mm gamma index passing rate criteria. Conclusion: All VMAT plans met the RTOG compliance criteria for WBRT, hippocampi, optic chiasm/nerve constraints. VMAT provided highly conformal and homogenous plans with an accurate and efficient option for WBRT with hippocampal sparing. VMAT planning used less MUs and required less beam on time than traditional IMRT based planning for WBRT with hippocampal sparing. VMAT also significantly reduce doses to other OARs compared to NC-WBRT. We plan to test our VMAT WBRT hippocampal sparing treatment approach in a larger group of patients to further validate these retrospective results including reduction of radiation dose to OARs as well as explore the clinical potential of concurrent boost. 
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Combined Proton-Photon Technique for Regional Nodal Irradiation in Breast Cancer J.A. Bradley, 1 M.W. Ho, 1 R. Dagan, 1 M.S. Rutenberg, 1 Z. Li, 1 and N.P. Mendenhall 2 ; 1 University of Florida, Jacksonville, FL, 2 University of Florida Health Proton Therapy Institute, Jacksonville, FL Purpose/Objective(s): The optimal radiation therapy (RT) technique for breast cancer depends on an individual patient's anatomy. Women with pendulous breasts or tissue expanders are two groups in which optimal target coverage and organ-at-risk (OAR) sparing can be difficult to simultaneously achieve with any single modality. The purpose of this study is to describe a combined proton-photon technique for breast cancer patients requiring regional nodal irradiation. Materials/Methods: A matched proton-photon technique was developed in which proton therapy was used to treat the supraclavicular nodes, the high axillary nodes, and the internal mammary nodes (IMN). Narrow parallelopposed photon tangents were used to treat the breast tissue or the chest Poster Viewing Abstracts 3555; Table 1 Photon Proton 
